Hello all, and happy hump-day. It wasn't an especially happy day for investors, of course, who watched stocks log a fifth straight day of losses, pulling the indices below key support levels in the process. We'll look at it below, as we usually do. First though, a couple of news items from our list of Featured Stocks. Remember Biotricity (BTCY)? This was the medical device company developing a remote-monitoring technology for (among others) heart patients. The last we heard about BTCY was the October 25th announcement that it was indeed expanding its scope, planning on using its remote-monitoring capabilities to enter the fetal monitoring, sleep apnea monitoring, and peri-operative monitoring markets to its list of targets. We still contend the proverbial big Kahuna, however, was the October 18th news that the FDA has given 510k clearance for a key part of its bioflux heart monitoring device. That green light pushed BTCY one step closer to entering the $20 billion heart monitoring market. Today's news will pale in comparison, but it's noteworthy nonetheless -- cardiologist Dr. Rony Shimony has joined Biotricity's Board of Advisors. The name may not be as recognizable as Tom Brady's or Brad Pitt's, but within healthcare circles it's a name that turns heads. There's an old saying.... in business, it's not what you know but who you know. Well, Biotricity certainly knows plenty about what it takes to introduce a successful piece of medical technology to the healthcare market. But, with Shimony on board, the company has another arrow in its quiver, so to speak. He's a guy who knows people, and a guy people want to know. More than anything though, he's a guy people respect and will listen to. It was also a big news day for Staffing 360 Solutions (STAF), which delivered a letter to shareholders letting them know the company was still going full steam ahead with its growth and acquisition strategy, and simultaneously addressing the fact that STAF shares recently broke below a price of $1.00. It's a potential problem, since its NASDAQ listing requires it to hold above that price. Just check out the letter from Executive Chairman Brendan Flood for the full scoop. We'll just sum it up for you by saying we agree with Flood... this weakness is a temporary thing, and the price of STAF is apt to be restored before it becomes an issue. As a reminder, Staffing 360 Solutions has done $177 million worth of revenue over the course of the past four quarters, and last quarter swung to a decidedly-positive EBITDA as well as decidedly widened its gross profits. Persistent net income is in sight. Yet, STAF currently sports an inexplicably low market cap of $7.7 million. That's nuts. The mathematical enterprise value alone is registering right around $31 million, but even that's still low. Throw in the fact that Staffing 360 Solutions is on pace to generate $300 million in annual revenue in the foreseeable future, and the justification for a much higher stock price takes shape. So what's the deal? We suspect the market is afraid of dilution - Staffing 360 Solutions has partially been funding its acquisitions with stock. It's not an unreasonable concern. It's arguably an overblown concern though. STAF has been getting a great return on its investment, and on a sales-per-share basis is holding pretty steady as it swaps stock for new organizations. It should be viewed as an investment in its future rather than just an expense. And, that realization should materialize in time, as Flood suggested in the letter. Another progressive quarter or two could sufficiently make the point, though we think STAF shares could turn around preemptively. In any case, with the Fed not giving investors any reason to change their mind about what the future holds (once again, Janet Yellen said a whole lot of nothing), stocks just kept doing today what they did for the prior four trading days. That is, they lost ground. Not that such a move wasn't in the cards, but the way this one is taking shape presents some problems. The biggest problem? The risk of getting a "good enough" corrective move without actually hitting the market's reset button in a big way that we could call a true capitulation. That's fine if we do, but if the pullback is only something on the order of 5% or so, we're going to be right back in the lethargic mess we were in just a couple of months ago. We'd actually be better off swallowing that bitter pill now, right-sizing valuations, and then picking up the pieces again to start the next leg of the bull market. That's my fancy way of saying if five straight days of losses turns into six or seven straight days of losses and the S&P 500 ends up touching that 200-day moving average line at 2081, the masses might be willing to treat that dip as a bottom. Ironically, the best thing for the bears here might be a bit of a bounce for a day or two and then a resumption of the downtrend that carries the S&P 500 to lower lows .... and most importantly, below the 200-day moving average line. My guess is, we will see the bulls push back sooner or later here. The VIX is looking toppy, even if only for the short-term. If the bulls push and then that effort fades, I can see traders really throwing in the towel. We'd suggest being strong buyers a few days later. The less likely outcome here is a continued beeline to the 200-day moving average line. If that happens, things become a bit of a toss-up. In other words, pacing is everything. We still contend a correction is going to be a necessary evil if we ever want to make progress at a decent pace again. Stock prices right now are about six months ahead of their actual/likely earnings, and stagnation like we've seen since July doesn't solve the problem. It's going to take a big dip to solve the problem. That's the way we see it anyway. But hey - if you don't like that assessment, check back in as early as tomorrow. This crazy market continues to throw unexpected curve balls, and now the Presidential election uncertainty is forcing investors to rethink things they weren't planning on rethinking.